Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 3/20 | 0.59 |
| ▸ | TRPM8 | Q7Z2W7 | 4/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9951381 | 0.84 | EPHX1 (0.51) | EPHX1TRPM8TRPA1ALDH1A1TRPV1 | |
| SCHEMBL28350744 | 0.84 | EPHX1 (0.51) | EPHX1TRPM8TRPA1ALDH1A1HPGD | |
| SCHEMBL9951688 | 0.84 | EPHX1 (0.51) | EPHX1TRPM8TRPA1ALDH1A1TRPV1 | |
| SCHEMBL457824 | 0.84 | EPHX1 (0.51) | EPHX1TRPM8TRPA1TRPV1CYP19A1 | |
| SCHEMBL9951572 | 0.84 | EPHX1 (0.51) | EPHX1TRPM8TRPA1TRPV1CYP19A1 | |
| Acetic Acid SCHEMBL30541669 | 0.81 | EPHX1 (0.49) | EPHX1TRPM8TRPA1TRPV1CYP19A1 | |
| Formaldehyde SCHEMBL31298519 | 0.81 | EPHX1 (0.49) | EPHX1TRPM8TRPA1TRPV1CYP19A1 | |
| SCHEMBL11291061 | 0.81 | EPHX1 (0.49) | EPHX1TRPM8TRPA1ALDH1A1TRPV1 | |
| SCHEMBL3793761 | 0.79 | EPHX1 (0.47) | EPHX1TRPM8TRPA1TRPV1 | |
| SCHEMBL23718853 | 0.78 | EPHX1 (0.46) | EPHX1TRPM8TRPA1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 294 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107954824-B | Method for synthesizing menthane carboxamide by using menthol | 昆山亚香香料股份有限公司 | 2022-12-27 | — | — | CN | claimed |
| EP-4103287-A1 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS AND COOLING AGENTS | Symrise AG (DE) | 2022-12-21 | — | — | EP | claimed |
| WO-2022122903-A1 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS AND COOLING AGENTS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | claimed |
| WO-2022122134-A1 | COMPOSITIONS WITH (BIO)-ALKANEDIOLS AND COOLING AGENTS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | claimed |
| EP-4734939-A2 | ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACIDS | The Procter & Gamble Company (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-4734922-A2 | ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACIDS AND TIN | The Procter & Gamble Company (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-4447907-B1 | ORAL CARE COMPOSITION COMPRISING PHYTATES AND PIGMENT | UNILEVER IP HOLDINGS B V (NL) | 2026-04-22 | — | — | EP | disclosed |
| US-20260102322-A1 | ORAL CARE COMPOSITIONS COMPRISING CARBOXYLIC ACIDS | PROCTER & GAMBLE (US) | 2026-04-16 | — | — | US | disclosed |
| US-20260083649-A1 | ORAL CARE COMPOSITIONS COMPRISING MINT OIL AND TIN | PROCTER & GAMBLE (US) | 2026-03-26 | — | — | US | disclosed |
| US-20260076894-A1 | ORAL CARE COMPOSITIONS COMPRISING HOPS AND TIN | PROCTER & GAMBLE (US) | 2026-03-19 | — | — | US | disclosed |
| US-12551414-B2 | Systems and methods for delivering active agents | THE PROCTER & GAMBLE COMPANY (US) | 2026-02-17 | — | — | US | disclosed |
| EP-4133047-B1 | CLEANING ARTICLE WITH PREFERENTIAL RHEOLOGICAL SOLID COMPOSITION | PROCTER & GAMBLE (US) | 2026-02-11 | — | — | EP | disclosed |
| EP-3373895-A1 | REDUCTION OF STINGING SENSATION ON SKIN | Symrise AG (DE) | 2018-09-19 | — | — | EP | disclosed |
| US-20180185301-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING POLYALKYLENE GLYCOL DERIVATIVES | SYMRISE AG (DE) | 2018-07-05 | — | — | US | disclosed |
| WO-2017080625-A1 | REDUCTION OF STINGING SENSATION ON SKIN | SYMRISE AG (DE) | 2017-05-18 | — | — | WO | disclosed |
| EP-3081207-A1 | WHITENING COMPOSITIONS | Symrise AG (DE) | 2016-10-19 | — | — | EP | disclosed |
| WO-2014198366-A1 | GLOVE WITH A COOLING EFFECT | CARL FREUDENBERG KG (DE) | 2014-12-18 | — | — | WO | disclosed |
| US-20120165559-A1 | Compounds Having a Physiological Effect | V. MANE FILS (FR) | 2012-06-28 | — | — | US | disclosed |
| US-20120165559-A1 | Compounds Having a Physiological Effect | V. MANE FILS (FR) | 2012-06-28 | — | — | US | disclosed |
| WO-2010122239-A1 | COMPOUNDS HAVING A PHYSIOLOGICAL EFFECT | V. MANE FILS (FR) | 2010-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083649-A1 | ORAL CARE COMPOSITIONS COMPRISING MINT OIL AND TIN | TAS2R40, SOD1, TAS2R10 | EPHX1 4819/4885TRPM8 123/4885TRPA1 416/4885 |
| US-20260102322-A1 | ORAL CARE COMPOSITIONS COMPRISING CARBOXYLIC ACIDS | OTC, ODC1, SDC1 | EPHX1 4323/4885TRPM8 1265/4885TRPA1 2330/4885 |
| US-20260076894-A1 | ORAL CARE COMPOSITIONS COMPRISING HOPS AND TIN | SOD1, SOD3, HMBS | EPHX1 4797/4885TRPM8 236/4885TRPA1 435/4885 |
| US-12551414-B2 | Systems and methods for delivering active agents | CRYZ, CRY2, SMARCA1 | EPHX1 1634/4885TRPM8 3428/4885TRPA1 2723/4885 |
| US-20180185301-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING POLYALKYLENE GLYCOL DERIVATIVES | PARG, PARN, TRPV1 | EPHX1 1542/4885TRPM8 199/4885TRPA1 74/4885 |
| US-20120165559-A1 | Compounds Having a Physiological Effect | NPPA, CYP11B2, SHBG | EPHX1 871/4885TRPM8 412/4885TRPA1 418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.